Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Snail Institute (ISI) is a research-driven biotechnology organization focused on the study and application of snail mucin for healthcare and cosmetic purposes. Established as a spin-off from Chulalongkorn University in Thailand, the institute leverages over 30 years of malacological research to develop high-purity bioactive compounds. Their proprietary extraction technology isolates specific proteins, peptides, and glycosaminoglycans from snail secretions that exhibit potent antimicrobial, wound-healing, and anti-aging properties. The institute's research underpins the commercial skincare brand Snail 8, which utilizes evidence-based formulations for skin regeneration. Beyond cosmetics, ISI is actively investigating the therapeutic potential of snail-derived substances for medical applications such as chronic wound management and tissue repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Snail Institute.